have been shown to enhance responses to chemotherapy and ICB in mouse melanoma models by secreting SagA, which hydrolyzes bacterial peptidoglycans to create muropeptides that activate NOD2 signaling in macrophages, triggering immune activation (Griffin et al., 2021). This evidence concerns the gene NOD2 and melanoma.